Abstract:Autosomal-dominant spinocerebellar ataxias constitute a large, heterogeneous group of progressive neurodegenerative diseases with multiple types. To date, classical genetic studies have revealed 31 distinct genetic forms of spinocerebellar ataxias and identified 19 causative genes. Traditional positional cloning strategies, however, have limitations for finding causative genes of rare Mendelian disorders. Here, we used a combined strategy of exome sequencing and linkage analysis to identify a novel spinocerebellar ataxia causative gene, TGM6. We sequenced the whole exome of four patients in a Chinese four-generation spinocerebellar ataxia family and identified a missense mutation,c.1550T-G transition (L517W), in exon 10 of TGM6. This change is at a highly conserved position, is predicted to have a functional impact, and completely cosegregated with the phenotype. The exome results were validated using linkage analysis. The mutation we identified using exome sequencing was located in the same region (20p13-12.2) as that identified by linkage analysis, which cross-validated TGM6 as the causative spinocerebellar ataxia gene in this family. We also showed that the causative gene could be mapped by a combined method of linkage analysis and sequencing of one sample from the family. We further confirmed our finding by identifying another missense mutation c.980A-G transition (D327G) in exon seven of TGM6 in an additional spinocerebellar ataxia family, which also cosegregated with the phenotype. Both mutations were absent in 500 normal unaffected individuals of matched geographical ancestry. The finding of TGM6 as a novel causative gene of spinocerebellar ataxia illustrates whole-exome sequencing of affected individuals from one family as an effective and cost efficient method for mapping genes of rare Mendelian disorders and the use of linkage analysis and exome sequencing for further improving efficiency.

Dominant spinocerebellar ataxias: a molecular approach to classification, diagnosis, pathogenesis and the future

Spinocerebellar ataxias: from pathogenesis to recent therapeutic advances

Recent Progress in the Molecular Genetics of Spinocerebellar Ataxias (Scas)

Autosomal dominant cerebellar ataxias: new genes and progress towards treatments

Molecular genetics study of hereditary spastic paraplegia accompanied by distal amyotrophy-an update

Gene Deregulation and Underlying Mechanisms in Spinocerebellar Ataxias With Polyglutamine Expansion

Polyglutamine spinocerebellar ataxias — from genes to potential treatments

Recent advances in understanding dominant spinocerebellar ataxias from clinical and genetic points of view

Overarching pathomechanisms in inherited peripheral neuropathies, spastic paraplegias, and cerebellar ataxias

Hereditary Ataxias: From Bench to Clinic, Where Do We Stand?

Polyglutamine spinocerebellar ataxias: emerging therapeutic targets

Tgm6 Identified As A Novel Causative Gene of Spinocerebellar Ataxias Using Exome Sequencing

Emerging therapies in hereditary ataxias

Extreme phenotypic heterogeneity in non-expansion spinocerebellar ataxias

The Clinical Features and Gene Mutation Analysis in a Pedigree of Spinocerebellar Ataxia Type 7

Spinocerebellar Ataxia: Relationship Between Phenotype and Genotype – a Review

A Neurodevelopmental Viewpoint

Synergistic Toxicity of Polyglutamine-Expanded TATA-Binding Protein in Glia and Neuronal Cells: Therapeutic Implications for Spinocerebellar Ataxia 17.

Spinocerebellar ataxia: relationship between phenotype and genotype-A Review.

Functional implications of paralog genes in polyglutamine spinocerebellar ataxias

Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7